Yüklüyor......
Reslizumab in the management of poorly controlled asthma: the data so far
Interleukin-5, an important cytokine in the pathophysiology of asthma, participates in terminal maturation and increases chemotaxis, endothelial adhesion, and activation of eosinophils. Blockade of interleukin-5 activity with monoclonal antibodies have been successful in decreasing eosinophil counts...
Kaydedildi:
| Yayımlandı: | J Asthma Allergy |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5012840/ https://ncbi.nlm.nih.gov/pubmed/27621657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S94164 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|